Fluorinated 4-azasteroid derivatives as androgen receptor modulators

Details for Australian Patent Application No. 2003218235 (hide)

Owner Merck & Co., Inc.

Inventors Perkins, James J; Meissner, Robert S

Agent Spruson & Ferguson

Pub. Number AU-B-2003218235

PCT Number PCT/US03/08277

PCT Pub. Number WO2003/077919

Priority 60/363,822 13.03.02 US

Filing date 7 March 2003

Wipo publication date 29 September 2003

Acceptance publication date 15 May 2008

International Classifications

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/138 (2006.01) - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine

A61K 31/22 (2006.01)

A61K 31/366 (2006.01) - having six-membered rings, e.g. delta-lactones

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/404 (2006.01)

A61K 31/4418 (2006.01) - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. cyproheptadine

A61K 31/4535 (2006.01)

A61K 31/47 (2006.01) - Quinolines

A61K 31/473 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines

A61K 31/505 (2006.01) - Pyrimidines

A61K 31/565 (2006.01) - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

A61K 31/566 (2006.01) - having an oxo group in position 17, e.g. oestrone

A61K 31/567 (2006.01) - substituted in position 17 alpha, e.g. mestranol, norethandrolone

A61K 31/57 (2006.01) - substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone

A61K 31/573 (2006.01)

A61K 31/58 (2006.01) - containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin

A61K 31/59 (2006.01) - Compounds containing 9,10-seco-cyclopenta[a]hydro- phenanthrene ring systems

A61K 31/593 (2006.01)

A61K 31/661 (2006.01) - Phosphorus acids or esters thereof not having PC bonds, e.g. fosfosal, dichlorvos, malathion

A61K 31/663 (2006.01)

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

A61K 33/16 (2006.01) Medicinal preparations containing inorganic active ingredients - Fluorine compounds

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 60/363,822 13.03.02 US

6 November 2003 Application Open to Public Inspection

  Published as AU-B-2003218235

15 May 2008 Application Accepted

  Published as AU-B-2003218235

11 September 2008 Standard Patent Sealed

21 January 2010 Amendment Made

  The nature of the amendment is: Amend the patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

4 October 2012 Alteration of Name

  The name of the patentee has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003218236-Transgenic non-human mammals expressing constitutively activated tyrosine kinase receptors

2003218234-METHODS OF EXPRESSING NONENDOGENOUS G PROTEIN COUPLED RECEPTORS IN CELLS